Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 20/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25121128 | 0.93 | GLP1R (0.49) | GLP1RHTR1ACYP2C8KCNH2 | |
| SCHEMBL25465760 | 0.90 | GLP1R (0.47) | GLP1RHTR1ACYP2C8KCNH2 | |
| SCHEMBL25465763 | 0.83 | GLP1R (0.49) | GLP1R | |
| SCHEMBL25121202 | 0.83 | GLP1R (0.54) | GLP1RHTR1ACYP2C8KCNH2 | |
| SCHEMBL25121331 | 0.83 | GLP1R (0.58) | GLP1RHTR1ACYP2C8KCNH2 | |
| SCHEMBL25121129 | 0.83 | GLP1R (0.47) | GLP1RHTR1ACYP2C8KCNH2 | |
| SCHEMBL25465659 | 0.82 | GLP1R (0.73) | GLP1RHTR1ACYP2C8KCNH2 | |
| SCHEMBL25121124 | 0.80 | GLP1R (0.57) | GLP1RHTR1ACYP2C8KCNH2 | |
| SCHEMBL31120408 | 0.76 | GLP1R (0.80) | GLP1RHTR1ACYP2C8KCNH2 | |
| SCHEMBL25121200 | 0.76 | GLP1R (0.47) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150998-A1 | COMPOUNDS AS GLP-1R AGONISTS | Terns, Inc. | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150998-A1 | COMPOUNDS AS GLP-1R AGONISTS | GLP1R, GIPR, GCGR | GLP1R 1/4885HTR1A 246/4885CYP2C8 2376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.